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Cutaneous leiomyosarcoma is a rare malignant mesenchymal tumor of smooth muscle origin of unknown etiology. Leiomyosarcomas 
located on the skin include superficial leiomyosarcomas and metastatic leiomyosarcomas. Superficial leiomyosarcomas represent 
7–10% of all cases of leiomyosarcoma and are subdivided into cutaneous and subcutaneous lesions based on skin location. We re-
port a case of an 81-year-old woman who presented a slow growing tender single nodule on the left thigh and describe its clinical 
and dermoscopic features.
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An 81-year-old woman was referred to our clinic 
for the presence of a slow growing tender single 
nodule on the left thigh. The patient reported that the 
tumor had started to grow slowly one year ago with 
no symptoms. The patient was in apparently good 
health condition in consideration of her age.
On physical examination the lesion appeared 
as a firm, skin-colored, sessile nodule on the left 
thigh (Fig. 1). There were no palpable lymph nodes 
on the left groin. Dermoscopic examination revealed 
an aspecific non-pigmented pattern with the pre-
sence of arborizing vessels and spread telangiectasias 
on a background of whitish area that resembled the 
dermoscopic pattern of non-pigmented basal cell 
carcinoma. In addition, there was a thicker vessel 
on the peripheral area of the lesion. The vessel partially 
surrounded the lesion (Fig. 1). On the basis of this 
undefined clinical and dermoscopic aspect of the le-
sion we decided to perform an excisional biopsy with 
histological examination.
The histological examination showed a dermally 
based proliferation of spindle cells with blunt-ended, 
“cigar-shaped” nuclei and multiple mitotic figures that 
raveled the diagnosis of cutaneous leiomyosarcoma 
(Fig. 2). Morphological diagnosis was supported 
by immunohistochemical positivity of tumor cells 
with smooth muscle markers (smooth muscle actin 
1A4, common muscle actin HHF35 and desmin). 
The patient was surgically retreated with a wide local 
excision, with 2-cm lateral margins. After 24 months 
of follow up she resulted negative for the presence 
of local recurrence and with no evidence of disease 
recurrence or metastasis.
DISCUSSION
Cutaneous leiomyosarcoma is a rare malignant 
mesenchymal tumor of smooth muscle origin of un-
known etiology [1]. Leiomyosarcomas located on the 
skin include superficial leiomyosarcomas and meta-
static leiomyosarcomas. Superficial leiomyosarcomas 
represent 7–10% of all cases of leiomyosarcoma and 
are subdivided into cutaneous and subcutaneous le-
sions based on skin location [2, 3]. The extremities 
are the most common body locations, particularly the 
face and neck area and the legs [4]. Histologically, cu-
taneous leiomyosarcomas are situated primarily in the 
dermis and extend occasionally into the subcutaneous 
fat tissue. These tumors are thought to arise from the 
arrector pili muscle of the hair follicle [1]. The develop-




Fig. 1. The nodule of approximately 2 cm in diameter appears firm, skin-colored and sessile (a, b). Dermoscopic examination 
revealed an aspecific non pigmented pattern with the presence of arborizing vessels and spread telangiectasias on a background 
of whitish area. A thicker vessel that partially surrounded the lesion is present on the peripheral area of the lesion (c)
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ment of metastases from cutaneous leiomyosarcoma 
is exceptional but these tumors may show aggressive 
biologic potential that can determinate a significant 
local destruction.
Clinically, a cutaneous leiomyosarcoma usually 
appears as a skin colored soft node with no specific 
features, therefore the potential differential diagnosis 
is with a number of lesions including common benign 
lesions such as cysts, lipomas, fibromas, persistent 
insect bites, pyogenic granuloma, neurofibromas, 
dermatofibromas, and intradermal nevi. Moreover, 
a cutaneous leiomyosarcoma can be misdiagnosed 
also with malignant cutaneous lesions such as basal 
cell carcinoma, squamous cell carcinoma, amelanotic 
melanoma and cutaneous metastasis of an internal 
malignancy. In our case, even if the clinical appear-
ance of the lesion did not allow for the diagnosis, the 
dermoscopic pattern brought us to suspect a malign 
lesion. The dermoscopic pattern of our lesion could 
be matched with the diagnosis of either basal cell 
carcinoma or amelanotic melanoma. Therefore the un-
defined pattern should suggest a diagnosis of a malig-
nant lesion that requires a prompt surgical treatment.
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Fig. 2. Cutaneous leiomyosarcoma: a — purely dermal cutane-
ous leiomyosarcoma showing a polypoid architecture (original 
magnification × 5); b — the tumor is composed of long intersect-
ing, occasionally perpendicular, fascicles of smooth muscle cells 
having an elongated shape, blunt-ended nuclei, and eosinophilic 
cytoplasm (original magnification × 20)
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